Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arvinas (ARVN) Research & Development (2017 - 2025)

Arvinas has reported Research & Development over the past 9 years, most recently at $61.1 million for Q4 2025.

  • Quarterly results put Research & Development at $61.1 million for Q4 2025, down 26.65% from a year ago — trailing twelve months through Dec 2025 was $285.2 million (down 18.09% YoY), and the annual figure for FY2025 was $285.2 million, down 18.09%.
  • Research & Development for Q4 2025 was $61.1 million at Arvinas, down from $64.7 million in the prior quarter.
  • Over the last five years, Research & Development for ARVN hit a ceiling of $103.4 million in Q2 2023 and a floor of $34.9 million in Q1 2021.
  • Median Research & Development over the past 5 years was $80.4 million (2022), compared with a mean of $75.4 million.
  • Biggest five-year swings in Research & Development: skyrocketed 90.89% in 2022 and later decreased 26.79% in 2025.
  • Arvinas' Research & Development stood at $61.9 million in 2021, then soared by 58.8% to $98.3 million in 2022, then dropped by 3.15% to $95.2 million in 2023, then fell by 12.5% to $83.3 million in 2024, then fell by 26.65% to $61.1 million in 2025.
  • The last three reported values for Research & Development were $61.1 million (Q4 2025), $64.7 million (Q3 2025), and $68.6 million (Q2 2025) per Business Quant data.